INNOVA CAPTAB
Quarterly Results Analysis [Sep2025]
INNOVA CAPTAB Quarterly Results
| Consolidated | Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹380 Cr | ₹352 Cr | ₹315 Cr | ₹316 Cr | ₹318 Cr | ₹294 Cr | ₹263 Cr | ₹302 Cr |
| Expenses | ₹329 Cr | ₹299 Cr | ₹267 Cr | ₹270 Cr | ₹268 Cr | ₹252 Cr | ₹225 Cr | ₹258 Cr |
| Operating Income | ₹52 Cr | ₹52 Cr | ₹48 Cr | ₹47 Cr | ₹50 Cr | ₹42 Cr | ₹38 Cr | ₹45 Cr |
| Other Income | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹6 Cr | ₹2 Cr |
| Interest | ₹5 Cr | ₹3 Cr | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹7 Cr |
| Depreciation | ₹11 Cr | ₹11 Cr | ₹10 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹3 Cr | ₹5 Cr |
| Profit Before Tax | ₹39 Cr | ₹43 Cr | ₹39 Cr | ₹46 Cr | ₹47 Cr | ₹39 Cr | ₹40 Cr | ₹35 Cr |
| Profit After Tax | ₹30 Cr | ₹31 Cr | ₹30 Cr | ₹34 Cr | ₹35 Cr | ₹29 Cr | ₹29 Cr | ₹25 Cr |
| EPS | ₹5.18 | ₹5.42 | ₹5.17 | ₹5.98 | ₹6.12 | ₹5.15 | ₹5.02 | ₹4.39 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| INNOVA CAPTAB | -6.5% | -6.5% | -32.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.2% | 2.3% | -1.1% |
| DIVIS LABORATORIES | 0.9% | -2.5% | 8.3% |
| CIPLA | 1.1% | -1.6% | 4.3% |
| TORRENT PHARMACEUTICALS | 0.5% | -1.5% | 12.3% |
| DR REDDYS LABORATORIES | 2.7% | 2.9% | 3.3% |
| MANKIND PHARMA | -1.7% | -5.5% | -16.9% |
| ZYDUS LIFESCIENCES | 0.2% | -2.4% | -5.8% |
| LUPIN | 1.9% | 1.7% | -1.6% |
INNOVA CAPTAB Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 8.20 % |
| Y-o-Y | 19.54 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Sep2025 | ₹380 Cr | 8.20 | |
| Jun2025 | ₹352 Cr | 11.69 | |
| Mar2025 | ₹315 Cr | -0.54 | |
| Dec2024 | ₹316 Cr | -0.55 | |
| Sep2024 | ₹318 Cr | 8.13 | |
| Jun2024 | ₹294 Cr | 12.05 | |
| Mar2024 | ₹263 Cr | -13.17 | |
| Dec2023 | ₹302 Cr | - | |
INNOVA CAPTAB Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -0.46 % |
| Y-o-Y | 4.27 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Sep2025 | ₹52 Cr | -0.46 | |
| Jun2025 | ₹52 Cr | 9.26 | |
| Mar2025 | ₹48 Cr | 2.41 | |
| Dec2024 | ₹47 Cr | -6.38 | |
| Sep2024 | ₹50 Cr | 17.92 | |
| Jun2024 | ₹42 Cr | 10.76 | |
| Mar2024 | ₹38 Cr | -14.62 | |
| Dec2023 | ₹45 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -8.03 % |
| Y-o-Y | -12.80 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Sep2025 | 13.63% | -8.03 | |
| Jun2025 | 14.82% | -2.18 | |
| Mar2025 | 15.15% | 2.99 | |
| Dec2024 | 14.71% | -5.89 | |
| Sep2024 | 15.63% | 9.07 | |
| Jun2024 | 14.33% | -1.17 | |
| Mar2024 | 14.5% | -1.63 | |
| Dec2023 | 14.74% | - | |
INNOVA CAPTAB Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -4.34 % |
| Y-o-Y | -15.24 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Sep2025 | ₹30 Cr | -4.34 | |
| Jun2025 | ₹31 Cr | 4.88 | |
| Mar2025 | ₹30 Cr | -13.54 | |
| Dec2024 | ₹34 Cr | -2.29 | |
| Sep2024 | ₹35 Cr | 18.75 | |
| Jun2024 | ₹29 Cr | 2.63 | |
| Mar2024 | ₹29 Cr | 14.31 | |
| Dec2023 | ₹25 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -11.56 % |
| Y-o-Y | -29.09 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Sep2025 | 7.8 % | -11.56 | |
| Jun2025 | 8.82 % | -6.17 | |
| Mar2025 | 9.4 % | -13.04 | |
| Dec2024 | 10.81 % | -1.73 | |
| Sep2024 | 11 % | 9.78 | |
| Jun2024 | 10.02 % | -8.41 | |
| Mar2024 | 10.94 % | 31.65 | |
| Dec2023 | 8.31 % | - | |
INNOVA CAPTAB Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -4.43 % |
| Y-o-Y | -15.36 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Sep2025 | ₹5.18 | -4.43 | |
| Jun2025 | ₹5.42 | 4.84 | |
| Mar2025 | ₹5.17 | -13.55 | |
| Dec2024 | ₹5.98 | -2.29 | |
| Sep2024 | ₹6.12 | 18.83 | |
| Jun2024 | ₹5.15 | 2.59 | |
| Mar2024 | ₹5.02 | 14.35 | |
| Dec2023 | ₹4.39 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD